When should a clinician tell a patient they have a gene variant that appeared incidentally but may have ramifications for cardiovascular health?

The model estimated mortality risk for more than 244,000 patients in Alberta, Canada, who had an ECG taken after a related health incident. 

Patients hospitalized for severe infectious diseases are at heightened risk of major cardiovascular-disease events within a month of admission date. 

Evkeeza, which was previously approved for patients ages 12 and above, was shown to help lower cholesterol for children with homozygous familial hypercholesterolemia (HoFH), in conjunction with other therapies. 

Only 65% of patients actually receive recommended additional imaging in this setting, with a median turnaround time of 50 days, according to a new study.

“Medications shouldn’t cost an arm and a leg, metaphorically or literally,” says Ohio Attorney General Dave Yost “Insulin is just a symptom of the problem; PBMs are the disease.”